Drug Approval | October 07, 2025
Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen is bioequivalent to Victoza Injection, 18 mg/3 mL (6 mg/mL) of Novo Nordisk
Hyperion results presented at ERS 2025 and simultaneously published in the New England Journal of Medicine
Through the new DTP platform, Novartis will make Cosentyx available to patients at a price that reflects the average savings typically retained by insurers and pharmacy benefit managers
The product will be manufactured at Lupin’s Chhatrapati Sambhajinagar facility in India
India currently hosts more than 10,075 biotech startups
Subscribe To Our Newsletter & Stay Updated
